Highlights
The global Neurovascular or Interventional Neurology Devices market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Neurovascular or Interventional Neurology Devices is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Neurovascular or Interventional Neurology Devices is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Neurovascular or Interventional Neurology Devices include Stryker, Medtronic, Johnson and Johnson, Terumo, Penumbra, Boston Scientific, Abbott Laboratories, Merit Medical Systems and Microport Scientific, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Neurovascular or Interventional Neurology Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurovascular or Interventional Neurology Devices.
The Neurovascular or Interventional Neurology Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Neurovascular or Interventional Neurology Devices market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neurovascular or Interventional Neurology Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Stryker
Medtronic
Johnson and Johnson
Terumo
Penumbra
Boston Scientific
Abbott Laboratories
Merit Medical Systems
Microport Scientific
Segment by Type
Cerebral Thrombectomy Devices
Carotid Artery Stenting (CAS) System
Cerebral Aneurysm and AVM Endovascular Embolization Systems
Intracranial Stent Systems
Flow Diverter for Aneurysm
Segment by Application
Hospital
Clinic
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Neurovascular or Interventional Neurology Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Neurovascular or Interventional Neurology Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Neurovascular or Interventional Neurology Devices 麻豆原创 Overview
1.1 Product Overview and Scope of Neurovascular or Interventional Neurology Devices
1.2 Neurovascular or Interventional Neurology Devices Segment by Type
1.2.1 Global Neurovascular or Interventional Neurology Devices 麻豆原创 Value Comparison by Type (2023-2029)
1.2.2 Cerebral Thrombectomy Devices
1.2.3 Carotid Artery Stenting (CAS) System
1.2.4 Cerebral Aneurysm and AVM Endovascular Embolization Systems
1.2.5 Intracranial Stent Systems
1.2.6 Flow Diverter for Aneurysm
1.3 Neurovascular or Interventional Neurology Devices Segment by Application
1.3.1 Global Neurovascular or Interventional Neurology Devices 麻豆原创 Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Neurovascular or Interventional Neurology Devices 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Neurovascular or Interventional Neurology Devices Revenue 2018-2029
1.4.2 Global Neurovascular or Interventional Neurology Devices Sales 2018-2029
1.4.3 Global Neurovascular or Interventional Neurology Devices 麻豆原创 Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Neurovascular or Interventional Neurology Devices 麻豆原创 Competition by Manufacturers
2.1 Global Neurovascular or Interventional Neurology Devices Sales 麻豆原创 Share by Manufacturers (2018-2023)
2.2 Global Neurovascular or Interventional Neurology Devices Revenue 麻豆原创 Share by Manufacturers (2018-2023)
2.3 Global Neurovascular or Interventional Neurology Devices Average Price by Manufacturers (2018-2023)
2.4 Global Neurovascular or Interventional Neurology Devices Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Neurovascular or Interventional Neurology Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Neurovascular or Interventional Neurology Devices, Product Type & Application
2.7 Neurovascular or Interventional Neurology Devices 麻豆原创 Competitive Situation and Trends
2.7.1 Neurovascular or Interventional Neurology Devices 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Neurovascular or Interventional Neurology Devices Players 麻豆原创 Share by Revenue
2.7.3 Global Neurovascular or Interventional Neurology Devices 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Neurovascular or Interventional Neurology Devices Retrospective 麻豆原创 Scenario by Region
3.1 Global Neurovascular or Interventional Neurology Devices 麻豆原创 Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Neurovascular or Interventional Neurology Devices Global Neurovascular or Interventional Neurology Devices Sales by Region: 2018-2029
3.2.1 Global Neurovascular or Interventional Neurology Devices Sales by Region: 2018-2023
3.2.2 Global Neurovascular or Interventional Neurology Devices Sales by Region: 2024-2029
3.3 Global Neurovascular or Interventional Neurology Devices Global Neurovascular or Interventional Neurology Devices Revenue by Region: 2018-2029
3.3.1 Global Neurovascular or Interventional Neurology Devices Revenue by Region: 2018-2023
3.3.2 Global Neurovascular or Interventional Neurology Devices Revenue by Region: 2024-2029
3.4 North America Neurovascular or Interventional Neurology Devices 麻豆原创 Facts & Figures by Country
3.4.1 North America Neurovascular or Interventional Neurology Devices 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Neurovascular or Interventional Neurology Devices Sales by Country (2018-2029)
3.4.3 North America Neurovascular or Interventional Neurology Devices Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Neurovascular or Interventional Neurology Devices 麻豆原创 Facts & Figures by Country
3.5.1 Europe Neurovascular or Interventional Neurology Devices 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Neurovascular or Interventional Neurology Devices Sales by Country (2018-2029)
3.5.3 Europe Neurovascular or Interventional Neurology Devices Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Neurovascular or Interventional Neurology Devices 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Neurovascular or Interventional Neurology Devices 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Neurovascular or Interventional Neurology Devices Sales by Country (2018-2029)
3.6.3 Asia Pacific Neurovascular or Interventional Neurology Devices Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Neurovascular or Interventional Neurology Devices 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Neurovascular or Interventional Neurology Devices 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Neurovascular or Interventional Neurology Devices Sales by Country (2018-2029)
3.7.3 Latin America Neurovascular or Interventional Neurology Devices Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Neurovascular or Interventional Neurology Devices 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Neurovascular or Interventional Neurology Devices 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Neurovascular or Interventional Neurology Devices Sales by Country (2018-2029)
3.8.3 Middle East and Africa Neurovascular or Interventional Neurology Devices Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Neurovascular or Interventional Neurology Devices Sales by Type (2018-2029)
4.1.1 Global Neurovascular or Interventional Neurology Devices Sales by Type (2018-2023)
4.1.2 Global Neurovascular or Interventional Neurology Devices Sales by Type (2024-2029)
4.1.3 Global Neurovascular or Interventional Neurology Devices Sales 麻豆原创 Share by Type (2018-2029)
4.2 Global Neurovascular or Interventional Neurology Devices Revenue by Type (2018-2029)
4.2.1 Global Neurovascular or Interventional Neurology Devices Revenue by Type (2018-2023)
4.2.2 Global Neurovascular or Interventional Neurology Devices Revenue by Type (2024-2029)
4.2.3 Global Neurovascular or Interventional Neurology Devices Revenue 麻豆原创 Share by Type (2018-2029)
4.3 Global Neurovascular or Interventional Neurology Devices Price by Type (2018-2029)
5 Segment by Application
5.1 Global Neurovascular or Interventional Neurology Devices Sales by Application (2018-2029)
5.1.1 Global Neurovascular or Interventional Neurology Devices Sales by Application (2018-2023)
5.1.2 Global Neurovascular or Interventional Neurology Devices Sales by Application (2024-2029)
5.1.3 Global Neurovascular or Interventional Neurology Devices Sales 麻豆原创 Share by Application (2018-2029)
5.2 Global Neurovascular or Interventional Neurology Devices Revenue by Application (2018-2029)
5.2.1 Global Neurovascular or Interventional Neurology Devices Revenue by Application (2018-2023)
5.2.2 Global Neurovascular or Interventional Neurology Devices Revenue by Application (2024-2029)
5.2.3 Global Neurovascular or Interventional Neurology Devices Revenue 麻豆原创 Share by Application (2018-2029)
5.3 Global Neurovascular or Interventional Neurology Devices Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Stryker
6.1.1 Stryker Corporation Information
6.1.2 Stryker Description and Business Overview
6.1.3 Stryker Neurovascular or Interventional Neurology Devices Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Stryker Neurovascular or Interventional Neurology Devices Product Portfolio
6.1.5 Stryker Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Corporation Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Neurovascular or Interventional Neurology Devices Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Medtronic Neurovascular or Interventional Neurology Devices Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 Johnson and Johnson
6.3.1 Johnson and Johnson Corporation Information
6.3.2 Johnson and Johnson Description and Business Overview
6.3.3 Johnson and Johnson Neurovascular or Interventional Neurology Devices Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Johnson and Johnson Neurovascular or Interventional Neurology Devices Product Portfolio
6.3.5 Johnson and Johnson Recent Developments/Updates
6.4 Terumo
6.4.1 Terumo Corporation Information
6.4.2 Terumo Description and Business Overview
6.4.3 Terumo Neurovascular or Interventional Neurology Devices Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Terumo Neurovascular or Interventional Neurology Devices Product Portfolio
6.4.5 Terumo Recent Developments/Updates
6.5 Penumbra
6.5.1 Penumbra Corporation Information
6.5.2 Penumbra Description and Business Overview
6.5.3 Penumbra Neurovascular or Interventional Neurology Devices Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Penumbra Neurovascular or Interventional Neurology Devices Product Portfolio
6.5.5 Penumbra Recent Developments/Updates
6.6 Boston Scientific
6.6.1 Boston Scientific Corporation Information
6.6.2 Boston Scientific Description and Business Overview
6.6.3 Boston Scientific Neurovascular or Interventional Neurology Devices Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Boston Scientific Neurovascular or Interventional Neurology Devices Product Portfolio
6.6.5 Boston Scientific Recent Developments/Updates
6.7 Abbott Laboratories
6.6.1 Abbott Laboratories Corporation Information
6.6.2 Abbott Laboratories Description and Business Overview
6.6.3 Abbott Laboratories Neurovascular or Interventional Neurology Devices Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Abbott Laboratories Neurovascular or Interventional Neurology Devices Product Portfolio
6.7.5 Abbott Laboratories Recent Developments/Updates
6.8 Merit Medical Systems
6.8.1 Merit Medical Systems Corporation Information
6.8.2 Merit Medical Systems Description and Business Overview
6.8.3 Merit Medical Systems Neurovascular or Interventional Neurology Devices Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Merit Medical Systems Neurovascular or Interventional Neurology Devices Product Portfolio
6.8.5 Merit Medical Systems Recent Developments/Updates
6.9 Microport Scientific
6.9.1 Microport Scientific Corporation Information
6.9.2 Microport Scientific Description and Business Overview
6.9.3 Microport Scientific Neurovascular or Interventional Neurology Devices Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Microport Scientific Neurovascular or Interventional Neurology Devices Product Portfolio
6.9.5 Microport Scientific Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Neurovascular or Interventional Neurology Devices Industry Chain Analysis
7.2 Neurovascular or Interventional Neurology Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Neurovascular or Interventional Neurology Devices Production Mode & Process
7.4 Neurovascular or Interventional Neurology Devices Sales and 麻豆原创ing
7.4.1 Neurovascular or Interventional Neurology Devices Sales Channels
7.4.2 Neurovascular or Interventional Neurology Devices Distributors
7.5 Neurovascular or Interventional Neurology Devices Customers
8 Neurovascular or Interventional Neurology Devices 麻豆原创 Dynamics
8.1 Neurovascular or Interventional Neurology Devices Industry Trends
8.2 Neurovascular or Interventional Neurology Devices 麻豆原创 Drivers
8.3 Neurovascular or Interventional Neurology Devices 麻豆原创 Challenges
8.4 Neurovascular or Interventional Neurology Devices 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Stryker
Medtronic
Johnson and Johnson
Terumo
Penumbra
Boston Scientific
Abbott Laboratories
Merit Medical Systems
Microport Scientific
听
听
*If Applicable.
